Role of community pharmacists in the use of antipsychotics for behavioural and psychological symptoms of dementia (BPSD): a qualitative study

Ian D. Maidment, Lydia Aston, Andrea Hilton, Naveed Iqbal, Anne Child, Rachel Shaw

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: This study aimed to use qualitative methodology to understand the current role of community pharmacists in limiting the use of antipsychotics prescribed inappropriately for behavioural and psychological symptoms of dementia.

DESIGN: A qualitative study employing focus groups was conducted. Data were analysed using thematic analysis.

SETTING: 3 different geographical locations in the England.

PARTICIPANTS: Community pharmacists (n=22).

RESULTS: The focus groups identified an array of factors and constraints, which affect the ability of community pharmacists to contribute to initiatives to limit the use of antipsychotics. 3 key themes were revealed: (1) politics and the medical hierarchy, which created communication barriers; (2) how resources and remit impact the effectiveness of community pharmacy; and (3) understanding the nature of the treatment of dementia.

CONCLUSIONS: Our findings suggest that an improvement in communication between community pharmacists and healthcare professionals, especially general practitioners (GPs) must occur in order for community pharmacists to assist in limiting the use of antipsychotics in people with dementia. Additionally, extra training in working with people with dementia is required. Thus, an intervention which involves appropriately trained pharmacists working in collaboration with GPs and other caregivers is required. Overall, within the current environment, community pharmacists question the extent to which they can contribute in helping to reduce the prescription of antipsychotics.

LanguageEnglish
Article numbere010278
JournalBMJ Open
Volume6
Issue number3
DOIs
Publication statusPublished - 16 Mar 2016

Fingerprint

Behavioral Symptoms
Pharmacists
Antipsychotic Agents
Dementia
Psychology
Focus Groups
General Practitioners
Communication Barriers
Community Health Services
Aptitude
Pharmacies
Politics
England
Caregivers
Prescriptions
Communication

Bibliographical note

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Cite this

@article{07e7b77765bd4140b8778ac8fb95c7ed,
title = "Role of community pharmacists in the use of antipsychotics for behavioural and psychological symptoms of dementia (BPSD): a qualitative study",
abstract = "OBJECTIVE: This study aimed to use qualitative methodology to understand the current role of community pharmacists in limiting the use of antipsychotics prescribed inappropriately for behavioural and psychological symptoms of dementia.DESIGN: A qualitative study employing focus groups was conducted. Data were analysed using thematic analysis.SETTING: 3 different geographical locations in the England.PARTICIPANTS: Community pharmacists (n=22).RESULTS: The focus groups identified an array of factors and constraints, which affect the ability of community pharmacists to contribute to initiatives to limit the use of antipsychotics. 3 key themes were revealed: (1) politics and the medical hierarchy, which created communication barriers; (2) how resources and remit impact the effectiveness of community pharmacy; and (3) understanding the nature of the treatment of dementia.CONCLUSIONS: Our findings suggest that an improvement in communication between community pharmacists and healthcare professionals, especially general practitioners (GPs) must occur in order for community pharmacists to assist in limiting the use of antipsychotics in people with dementia. Additionally, extra training in working with people with dementia is required. Thus, an intervention which involves appropriately trained pharmacists working in collaboration with GPs and other caregivers is required. Overall, within the current environment, community pharmacists question the extent to which they can contribute in helping to reduce the prescription of antipsychotics.",
author = "Maidment, {Ian D.} and Lydia Aston and Andrea Hilton and Naveed Iqbal and Anne Child and Rachel Shaw",
note = "This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/",
year = "2016",
month = "3",
day = "16",
doi = "10.1136/bmjopen-2015-010278",
language = "English",
volume = "6",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "3",

}

Role of community pharmacists in the use of antipsychotics for behavioural and psychological symptoms of dementia (BPSD) : a qualitative study. / Maidment, Ian D.; Aston, Lydia; Hilton, Andrea; Iqbal, Naveed; Child, Anne; Shaw, Rachel.

In: BMJ Open, Vol. 6, No. 3, e010278, 16.03.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Role of community pharmacists in the use of antipsychotics for behavioural and psychological symptoms of dementia (BPSD)

T2 - BMJ Open

AU - Maidment, Ian D.

AU - Aston, Lydia

AU - Hilton, Andrea

AU - Iqbal, Naveed

AU - Child, Anne

AU - Shaw, Rachel

N1 - This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

PY - 2016/3/16

Y1 - 2016/3/16

N2 - OBJECTIVE: This study aimed to use qualitative methodology to understand the current role of community pharmacists in limiting the use of antipsychotics prescribed inappropriately for behavioural and psychological symptoms of dementia.DESIGN: A qualitative study employing focus groups was conducted. Data were analysed using thematic analysis.SETTING: 3 different geographical locations in the England.PARTICIPANTS: Community pharmacists (n=22).RESULTS: The focus groups identified an array of factors and constraints, which affect the ability of community pharmacists to contribute to initiatives to limit the use of antipsychotics. 3 key themes were revealed: (1) politics and the medical hierarchy, which created communication barriers; (2) how resources and remit impact the effectiveness of community pharmacy; and (3) understanding the nature of the treatment of dementia.CONCLUSIONS: Our findings suggest that an improvement in communication between community pharmacists and healthcare professionals, especially general practitioners (GPs) must occur in order for community pharmacists to assist in limiting the use of antipsychotics in people with dementia. Additionally, extra training in working with people with dementia is required. Thus, an intervention which involves appropriately trained pharmacists working in collaboration with GPs and other caregivers is required. Overall, within the current environment, community pharmacists question the extent to which they can contribute in helping to reduce the prescription of antipsychotics.

AB - OBJECTIVE: This study aimed to use qualitative methodology to understand the current role of community pharmacists in limiting the use of antipsychotics prescribed inappropriately for behavioural and psychological symptoms of dementia.DESIGN: A qualitative study employing focus groups was conducted. Data were analysed using thematic analysis.SETTING: 3 different geographical locations in the England.PARTICIPANTS: Community pharmacists (n=22).RESULTS: The focus groups identified an array of factors and constraints, which affect the ability of community pharmacists to contribute to initiatives to limit the use of antipsychotics. 3 key themes were revealed: (1) politics and the medical hierarchy, which created communication barriers; (2) how resources and remit impact the effectiveness of community pharmacy; and (3) understanding the nature of the treatment of dementia.CONCLUSIONS: Our findings suggest that an improvement in communication between community pharmacists and healthcare professionals, especially general practitioners (GPs) must occur in order for community pharmacists to assist in limiting the use of antipsychotics in people with dementia. Additionally, extra training in working with people with dementia is required. Thus, an intervention which involves appropriately trained pharmacists working in collaboration with GPs and other caregivers is required. Overall, within the current environment, community pharmacists question the extent to which they can contribute in helping to reduce the prescription of antipsychotics.

UR - http://www.scopus.com/inward/record.url?scp=84962273393&partnerID=8YFLogxK

UR - http://dx.doi.org/10.17036/2384fc6c-f3a5-425a-9827-616f1041df32

U2 - 10.1136/bmjopen-2015-010278

DO - 10.1136/bmjopen-2015-010278

M3 - Article

VL - 6

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 3

M1 - e010278

ER -